Treating severe COVID-19 associated secondary bacterial infections with Phage Therapy under the Declaration of Helsinki

Akronym

COVID-19_Phage

Bidragets beskrivning

Bacteriophages are viruses that infect and kill bacterial cells. SARS-Cov-2 infektion weakens the innate immune defense of lungs, which makes the patient susceptible to sometimes lethal bacterial pneumonia. Hospital acquired bacterial infections are often caused by pathogens that are resistant to antibiotics, which leaves very few treatment options. In the proposed project, we will isolate and prepare bacteriophages against the most problematic antibiotic resistant bacterial pathogens causing secondary infections in severe cases of COVID-19.
Visa mer

Startår

2020

Slutår

2022

Beviljade finansiering

Matti Jalasvuori Orcid -palvelun logo
188 217 €


Rollen i Finlands Akademis konsortium

Övriga parter i konsortiet

Partner
Helsingfors universitet (336519)
203 719 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt med särskild inriktning

Övriga uppgifter

Finansieringsbeslutets nummer

336518

Forskningsområden

Kliiniset lääketieteet

Temaområden

Lisätalousarvio III 2020

Identifierade teman

treatment, therapy